Seranova Bio, Inc. — Form D
Seranova Bio, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-13. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-05-13
- Form: D
- Accession: 0001862032-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 2
- Date of first sale: 2021-04-30
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-399247
Issuer
- Name: Seranova Bio, Inc.
- CIK: 0001862032
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 329 OYSTER POINT Boulevard, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 5099394681
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jim Tananbaum | Director | Thousand Oaks, CA |
| Beatrice McQueen | Executive Officer | Thousand Oaks, CA |
| Leon Chen | Director | Austin, TX |
| Aaron Ring | Director | Cambridge, MA |
| Aaron Ring | Executive Officer | Cambridge, MA |
| Hui Tian | Director | Cambridge, MA |
| Damien Soghoian | Director | Larkspur, CA |
| Damien Soghoian | Executive Officer | Larkspur, CA |
| Sabah Oney | Director | Philadelphia, PA |
Other filings by this issuer (1)
More